The WACC of Genomictree Inc (228760.KQ) is 6.6%.
| Range | Selected | |
| Cost of equity | 5.30% - 7.90% | 6.60% |
| Tax rate | -% - 2.10% | 1.05% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.3% - 7.9% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.3 | 0.48 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 5.30% | 7.90% |
| Tax rate | -% | 2.10% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.3% | 7.9% |
| Selected WACC | 6.6% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 228760.KQ:
cost_of_equity (6.60%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.3) + risk_adjustments (0.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.